SEQUENOM INC·4

Feb 11, 8:26 PM ET

SEQUENOM INC 4

4 · SEQUENOM INC · Filed Feb 11, 2016

Insider Transaction Report

Form 4
Period: 2016-02-10
VAN DEN BOOM DIRK
Director, Mol Biology
Transactions
  • Exercise/Conversion

    Common Stock

    2016-02-10+12,50083,044 total
  • Exercise/Conversion

    Common Stock

    2016-02-10+20,000103,044 total
  • Exercise/Conversion

    Restricted Stock Unit

    2016-02-1012,500878,630 total
    Common Stock (12,500 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2016-02-1020,000858,630 total
    Common Stock (20,000 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]The shares subject to the restricted stock unit began vesting in 4 equal annual installments commencing on 2/1/14, with annual vesting dates on 2/10/15, 2/10/16, 2/10/17 and 2/10/18 such the shares subject to the restricted stock units are fully vested on 2/10/18.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F4]The shares subject to the restricted stock unit began vesting in 4 equal annual installments commencing on 2/10/15, with annual vesting dates on 2/10/16, 2/10/17, 2/10/18 and 2/10/19 such the shares subject to the restricted stock units are fully vested on 2/10/19.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT